Source: Therapeutic Drug Monitoring. Unidades: FCFRP, FMRP
Subjects: NEUROLOGIA, CISTICERCOSE, INTERAÇÃO DE DROGAS, FARMACOCINÉTICA
ABNT
LANCHOTE, Vera Lúcia et al. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Therapeutic Drug Monitoring, v. 24, p. 338-345, 2002Tradução . . Acesso em: 12 nov. 2024.APA
Lanchote, V. L., Garcia, F. S., Dreossi, S. A. C., & Takayanagui, O. M. (2002). Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Therapeutic Drug Monitoring, 24, 338-345.NLM
Lanchote VL, Garcia FS, Dreossi SAC, Takayanagui OM. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Therapeutic Drug Monitoring. 2002 ; 24 338-345.[citado 2024 nov. 12 ]Vancouver
Lanchote VL, Garcia FS, Dreossi SAC, Takayanagui OM. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Therapeutic Drug Monitoring. 2002 ; 24 338-345.[citado 2024 nov. 12 ]